Document

Determination of Regulatory Review Period for Purposes of Patent Extension; OCREVUS

The Food and Drug Administration (FDA or the Agency) has

The Food and Drug Administration (FDA or the Agency) has

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

83 FR 52837

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Determination of Regulatory Review Period for Purposes of Patent Extension; OCREVUS,” thefederalregister.org (October 18, 2018), https://thefederalregister.org/documents/2018-22699/determination-of-regulatory-review-period-for-purposes-of-patent-extension-ocrevus.